149 related articles for article (PubMed ID: 34629879)
1. MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction].
Onco Targets Ther; 2021; 14():4963-4964. PubMed ID: 34629879
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-618 Directly Targets Metadherin mRNA To Suppress The Malignant Phenotype Of Osteosarcoma Cells By Reducing PTEN-AKT Pathway Output.
Li B; Zhao J; Zhao Q; Wu D; Zhang C; Zhao K; Song Y; Gao C
Onco Targets Ther; 2019; 12():9795-9807. PubMed ID: 31814737
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-559 Plays an Inhibitory Role in the Malignant Progression of Glioblastoma Cells by Directly Targeting Metadherin [Retraction].
Onco Targets Ther; 2021; 14():4899-4900. PubMed ID: 34594111
[TBL] [Abstract][Full Text] [Related]
5. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778
[TBL] [Abstract][Full Text] [Related]
6. microRNA-877 Inhibits Malignant Progression of Colorectal Cancer by Directly Targeting MTDH and Regulating the PTEN/Akt Pathway [Retraction].
Cancer Manag Res; 2021; 13():7489-7490. PubMed ID: 34611442
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].
Onco Targets Ther; 2021; 14():4935-4936. PubMed ID: 34611412
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction].
Onco Targets Ther; 2021; 14():4995-4996. PubMed ID: 34675540
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-876 is Sponged by Long Noncoding RNA LINC00707 and Directly Targets Metadherin to Inhibit Breast Cancer Malignancy [Retraction].
Cancer Manag Res; 2021; 13():7243-7244. PubMed ID: 34566430
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4961-4962. PubMed ID: 34675537
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-939 Directly Targets
Onco Targets Ther; 2021; 14():5001-5002. PubMed ID: 34675543
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression [Retraction].
Onco Targets Ther; 2021; 14():4743-4744. PubMed ID: 34526780
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200b Acts as a Tumor Suppressor in Osteosarcoma via Targeting ZEB1 [Retraction].
Onco Targets Ther; 2021; 14():4637-4638. PubMed ID: 34511931
[TBL] [Abstract][Full Text] [Related]
14. Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction].
Onco Targets Ther; 2023; 16():725-726. PubMed ID: 37694105
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-145 Inhibits the Activation of the mTOR Signaling Pathway to Suppress the Proliferation and Invasion of Invasive Pituitary Adenoma Cells by Targeting AKT3 in vivo and in vitro [Retraction].
Onco Targets Ther; 2020; 13():6851. PubMed ID: 32764974
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction].
Onco Targets Ther; 2021; 14():4991-4992. PubMed ID: 34675539
[TBL] [Abstract][Full Text] [Related]
17. microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4 [Retraction].
Onco Targets Ther; 2021; 14():4745-4746. PubMed ID: 34526781
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction].
Onco Targets Ther; 2023; 16():1023-1024. PubMed ID: 38090112
[TBL] [Abstract][Full Text] [Related]
19. Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction].
Onco Targets Ther; 2023; 16():275-276. PubMed ID: 37078010
[TBL] [Abstract][Full Text] [Related]
20. miR-141-3p is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma [Retraction].
Onco Targets Ther; 2023; 16():497-498. PubMed ID: 37408993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
